Corbus Pharmaceuticals's total assets for Q3 2024 were $164.17M, an increase of 8.02% from the previous quarter. CRBP total liabilities were $13.67M for the fiscal quarter, a -48.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.